Press releases

21/12/2017 18:00
|

Quantum Genomics to Present at Biotech Showcase 2018

15/11/2017 07:30
|

Quantum Genomics announces recruitment of first patients in the NEW-HOPE arterial hypertension study in the United States

27/10/2017 07:30
|

Quantum Genomics receives the Galien MedStartUp award for the innovative design of its NEW-HOPE study

16/10/2017 18:00
|

Quantum Genomics nominated for the Galien MedStartUp Award for the innovative design of its NEW-HOPE trial

03/10/2017 18:15
|

Quantum Genomics Releases 2017 First-Half Financial Results and First Nine Months Business Update

07/09/2017 18:00
|

Quantum Genomics to Present at Rodman and Renshaw 19th Annual Global Investment Conference

05/09/2017 18:00
|

Quantum Genomics Receives FDA Clearance of IND Application for QGC001

26/07/2017 08:45
|

Quantum Genomics raises EUR 8.2 Million in Europe and the U.S.

11/07/2017 07:30
|

Quantum Genomics begins trading in the U.S. on OTCQX

30/06/2017 07:30
|

Quantum Genomics appoints Professor Toshiro Fujita as member of its Scientific Advisory Board

28/06/2017 07:30
|

Quantum Genomics announces the design of its next Phase II trial in arterial hypertension, NEW-HOPE

19/06/2017 07:30
|

Quantum Genomics details positive results from its Phase IIa trial of QGC001 for the treatment of arterial hypertension

07/06/2017 18:20
|

Quantum Genomics to host two upcoming events

23/05/2017 18:00
|

Quantum Genomics to Host Key Opinion Leader Event Focused on Phase IIa Hypertension Data and the Upcoming Clinical Trial in the United States

09/05/2017 18:00
|

Quantum Genomics will organize a teleconference on June 19, 2017, to comment on phase IIa data in high blood pressure

25/04/2017 18:00
|

Quantum Genomics appoints Bruno Besse as Chief Medical Officer

30/03/2017 18:00
|

2016 annual financial results and next development steps in 2017

14/03/2017 18:00
|

Quantum Genomics announces positive data from new preclinical studies with QGC001

20/02/2017 18:00
|

2017 financial calendar - Quantum Genomics has joined the Pass French Tech program

02/02/2017 18:00
|

Quantum Genomics granted key European patent for QGC011 combination therapy program